RLX

RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share (RLX)

Stock · NYSE · Health Care

$1.7as of 10/16/2026

AI Market Commentary

AI-generatedAll commentary →

Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.

September 24, 2026

RLX Shares Drop to $1.79 Support Level. RLX shares have weakened, falling toward a key support level at $1.79. The RSI is 40.3, indicating a moderate pullback. Analysts see this as a potential buying opportunity, with a target range of $2.09 to $3.23. The price is still below the 52‑week low, so caution is advised.

Active signals

Resistance level
$1.97
Industry
Medicinal Chemicals and Botanical Products

What RLX's price did in the 20 trading sessions after each past signal, compared with any 20-session window over the same period.

SignalTimesMedian 20-session returnHigher after 20 sessions
Volume Spike36+1.1%50%
Bollinger Band Breakdown22-4.7%27%
Bollinger Band Breakout22+0.2%50%
200-Day Moving Average Touch14-1.2%43%
Any 20-session window (baseline)-1.6%45%

Computed by MarketWall from daily closing prices since May 18, 2022. Returns are close-to-close and don't include dividends. Past results describe what happened before; they are not a forecast and not investment advice.

About RLX

RLX Technology Inc., through its subsidiaries, develops, manufactures, and sells e-vapor products in the People's Republic of China and internationally. It offers rechargeable e-vapor products under the Qingyu, Phantom, Phantom Pro, Zeus, Leili, and Daqian names; and disposable e-vapor products under the Feiliu and Feiliu Mega names. The company also provides closed-system rechargeable products, open-system products,…

Sector
Health Care
Industry
Medicinal Chemicals and Botanical Products
Employees
897

Fundamentals

1-day range
$1.7$1.75
Market cap
$3.08B
P/E (trailing)
14.19
P/E (forward)
10.44
EPS (trailing)
$0.77
Dividend yield
5.15%
Beta
1.12
Avg. volume
3.10M
Ex-dividend date
January 26, 2026
Dividend pay date
February 9, 2026
52-week range
$1.65$2.6
Next earnings: November 13, 2026 · EPS estimate $0.23confirmed

Forecasts

6 analyst ratings

Buy 70%
Hold 30%
Sell 0%
1-year price forecast
High
$3.24
+90.7%
Median
$2.8
+64.9%
Low
$2.1
+23.4%

RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share Competitors

Chosen by industry and closest market cap.

  • RLX
    RLX Technology Inc. American Depositary Shares each representing the right to receive one (1) Class A ordinary share
    $1.7
    ▼ 0.58%
    Market cap $3.08BP/E 14.19
    $1.65$2.6
  • RGC
    Regencell Bioscience Holdings Limited Ordinary Shares
    $9.59
    ▲ 0.74%
    Market cap $2.70BP/E —
    $4.51$69
  • TRLV
    Trulieve Cannabis Corp. Subordinate Voting Shares
    $10.01
    ▼ 2.82%
    Market cap $1.73BP/E —
    $7.82$12.93
  • CRON
    Cronos Group Inc. Common Share
    $3.21
    ▲ 0.31%
    Market cap $1.16BP/E 16.88
    $3.23$4.99
  • DFTX
    Definium Therapeutics Inc. Common Shares
    $32.1
    ▼ 6.30%
    Market cap $5.03BP/E —
    $10.47$49.7
  • GLAS
    Glass House Brands Inc. Subordinate Voting Shares
    $3.19
    ▼ 14.02%
    Market cap $760.64MP/E —
    $4.2$14
  • TLRY
    Tilray Brands Inc. Common Stock
    $3.04
    ▼ 5.30%
    Market cap $517.36MP/E —
    $3.07$18.4

P/E shows — for peers not currently carrying a live signal of their own.

Latest news

Insider Activity

Insider Actions →
Acquired
3.20M
Disposed
0
  • Lu Chao · July 31, 2026 · Grant
    1.50M
  • Lu Chao · July 31, 2026 · Grant
    1.70M

Institutional Ownership

March 31, 2026

Total shares held
246.99M
Total value held
$517.55M
Institutional holders
98
Top holders this quarter
  • Unknown60.13M
  • Unknown57.13M
  • Unknown21.47M
  • Unknown13.19M
  • Unknown9.61M
  • Unknown9.52M
  • Unknown7.90M
  • Unknown7.50M
  • Unknown6.50M
  • Unknown6.05M

See the full, filterable feed with live charts on the MarketWall dashboard.

We use analytics to understand how market-wall is used. No personal data is sold.